304 related articles for article (PubMed ID: 23575995)
1. Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia.
Rowe CC; Pejoska S; Mulligan RS; Jones G; Chan JG; Svensson S; Cselényi Z; Masters CL; Villemagne VL
J Nucl Med; 2013 Jun; 54(6):880-6. PubMed ID: 23575995
[TBL] [Abstract][Full Text] [Related]
2. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.
Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL
J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients.
Byun BH; Kim BI; Park SY; Ko IO; Lee KC; Kim KM; Kim YK; Lee JY; Bu SH; Kim JH; Chi DY; Ha JH; Lim SM
Medicine (Baltimore); 2017 Mar; 96(12):e6441. PubMed ID: 28328855
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease.
Villemagne VL; Mulligan RS; Pejoska S; Ong K; Jones G; O'Keefe G; Chan JG; Young K; Tochon-Danguy H; Masters CL; Rowe CC
Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):983-9. PubMed ID: 22398958
[TBL] [Abstract][Full Text] [Related]
5. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
6. [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease.
Hatashita S; Yamasaki H; Suzuki Y; Tanaka K; Wakebe D; Hayakawa H
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):290-300. PubMed ID: 24085503
[TBL] [Abstract][Full Text] [Related]
7.
Higashi T; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
Ann Nucl Med; 2018 Apr; 32(3):206-216. PubMed ID: 29388083
[TBL] [Abstract][Full Text] [Related]
8. Determining Amyloid-β Positivity Using
Therriault J; Benedet AL; Pascoal TA; Savard M; Ashton NJ; Chamoun M; Tissot C; Lussier F; Kang MS; Bezgin G; Wang T; Fernandes-Arias J; Massarweh G; Vitali P; Zetterberg H; Blennow K; Saha-Chaudhuri P; Soucy JP; Gauthier S; Rosa-Neto P
J Nucl Med; 2021 Feb; 62(2):247-252. PubMed ID: 32737243
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal head-to-head comparison of
Chen CD; McCullough A; Gordon B; Joseph-Mathurin N; Flores S; McKay NS; Hobbs DA; Hornbeck R; Fagan AM; Cruchaga C; Goate AM; Perrin RJ; Wang G; Li Y; Shi X; Xiong C; Pontecorvo MJ; Klein G; Su Y; Klunk WE; Jack C; Koeppe R; Snider BJ; Berman SB; Roberson ED; Brosch J; Surti G; Jiménez-Velázquez IZ; Galasko D; Honig LS; Brooks WS; Clarnette R; Wallon D; Dubois B; Pariente J; Pasquier F; Sanchez-Valle R; Shcherbinin S; Higgins I; Tunali I; Masters CL; van Dyck CH; Masellis M; Hsiung R; Gauthier S; Salloway S; Clifford DB; Mills S; Supnet-Bell C; McDade E; Bateman RJ; Benzinger TLS;
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2669-2682. PubMed ID: 37017737
[TBL] [Abstract][Full Text] [Related]
10. Comparison of
Zeydan B; Schwarz CG; Przybelski SA; Lesnick TG; Kremers WK; Senjem ML; Kantarci OH; Min PH; Kemp BJ; Jack CR; Kantarci K; Lowe VJ
J Nucl Med; 2022 Aug; 63(8):1239-1244. PubMed ID: 34916245
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primates.
Schou M; Varnäs K; Sandell J; Johnström P; Cselenyi Z; Svensson S; Nakao R; Amini N; Bergman L; Sumic A; Gulyas B; Lindström-Böö E; Halldin C; Farde L
Mol Imaging Biol; 2014 Apr; 16(2):173-9. PubMed ID: 24002613
[TBL] [Abstract][Full Text] [Related]
12. Comparison of [
Lowe VJ; Lundt E; Knopman D; Senjem ML; Gunter JL; Schwarz CG; Kemp BJ; Jack CR; Petersen RC
Neuroimage Clin; 2017; 16():295-302. PubMed ID: 28856092
[TBL] [Abstract][Full Text] [Related]
13. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
Juréus A; Swahn BM; Sandell J; Jeppsson F; Johnson AE; Johnström P; Neelissen JA; Sunnemark D; Farde L; Svensson SP
J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
[TBL] [Abstract][Full Text] [Related]
14. Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.
Ito H; Shinotoh H; Shimada H; Miyoshi M; Yanai K; Okamura N; Takano H; Takahashi H; Arakawa R; Kodaka F; Ono M; Eguchi Y; Higuchi M; Fukumura T; Suhara T
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):745-54. PubMed ID: 24233004
[TBL] [Abstract][Full Text] [Related]
15. Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand.
Cselényi Z; Jönhagen ME; Forsberg A; Halldin C; Julin P; Schou M; Johnström P; Varnäs K; Svensson S; Farde L
J Nucl Med; 2012 Mar; 53(3):415-24. PubMed ID: 22323782
[TBL] [Abstract][Full Text] [Related]
16. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
Meyer PT; Hellwig S; Amtage F; Rottenburger C; Sahm U; Reuland P; Weber WA; Hüll M
J Nucl Med; 2011 Mar; 52(3):393-400. PubMed ID: 21321269
[TBL] [Abstract][Full Text] [Related]
17. Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.
Hong YT; Veenith T; Dewar D; Outtrim JG; Mani V; Williams C; Pimlott S; Hutchinson PJ; Tavares A; Canales R; Mathis CA; Klunk WE; Aigbirhio FI; Coles JP; Baron JC; Pickard JD; Fryer TD; Stewart W; Menon DK
JAMA Neurol; 2014 Jan; 71(1):23-31. PubMed ID: 24217171
[TBL] [Abstract][Full Text] [Related]
18. White Matter Reference Region in PET Studies of
Lowe VJ; Lundt ES; Senjem ML; Schwarz CG; Min HK; Przybelski SA; Kantarci K; Knopman D; Petersen RC; Jack CR
J Nucl Med; 2018 Oct; 59(10):1583-1589. PubMed ID: 29674420
[TBL] [Abstract][Full Text] [Related]
19. Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology.
Hatsuta H; Takao M; Ishii K; Ishiwata K; Saito Y; Kanemaru K; Arai T; Suhara T; Shimada H; Shinotoh H; Tamaoka A; Murayama S
Curr Alzheimer Res; 2015; 12(3):278-86. PubMed ID: 25731622
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal amyloid imaging using 11C-PiB: methodologic considerations.
van Berckel BN; Ossenkoppele R; Tolboom N; Yaqub M; Foster-Dingley JC; Windhorst AD; Scheltens P; Lammertsma AA; Boellaard R
J Nucl Med; 2013 Sep; 54(9):1570-6. PubMed ID: 23940304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
